250 related articles for article (PubMed ID: 23905047)
21. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
Goldsmith SR
Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
[TBL] [Abstract][Full Text] [Related]
22. [Use of "Vaptans" in treatment of hyponatremia].
Tanındı A; Töre HF
Turk Kardiyol Dern Ars; 2015 Apr; 43(3):292-301. PubMed ID: 25906004
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of hyponatraemia in hospitalised patients.
Reddy P; Mooradian AD
Int J Clin Pract; 2009 Oct; 63(10):1494-508. PubMed ID: 19769706
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hyponatremia: the role of lixivaptan.
Liamis G; Filippatos TD; Elisaf MS
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294
[TBL] [Abstract][Full Text] [Related]
25. Hyponatremia in patients with heart failure.
Filippatos TD; Elisaf MS
World J Cardiol; 2013 Sep; 5(9):317-28. PubMed ID: 24109495
[TBL] [Abstract][Full Text] [Related]
26. Involvement of arginine vasopressin and renal sodium handling in pathogenesis of hyponatremia in elderly patients.
Ishikawa S; Fujita N; Fujisawa G; Tsuboi Y; Sakuma N; Okada K; Saito T
Endocr J; 1996 Feb; 43(1):101-8. PubMed ID: 8732459
[TBL] [Abstract][Full Text] [Related]
27. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
[TBL] [Abstract][Full Text] [Related]
28. The Changing Role of Sodium Management in Cirrhosis.
Lizaola B; Bonder A; Tapper EB; Mendez-Bocanegra A; Cardenas A
Curr Treat Options Gastroenterol; 2016 Jun; 14(2):274-84. PubMed ID: 27037930
[TBL] [Abstract][Full Text] [Related]
29. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Lin TE; Adams KF; Patterson JH
Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436
[TBL] [Abstract][Full Text] [Related]
30. Hyponatremia in Heart Failure: Pathogenesis and Management.
Rodriguez M; Hernandez M; Cheungpasitporn W; Kashani KB; Riaz I; Rangaswami J; Herzog E; Guglin M; Krittanawong C
Curr Cardiol Rev; 2019; 15(4):252-261. PubMed ID: 30843491
[TBL] [Abstract][Full Text] [Related]
31. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
Miller M
J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
[TBL] [Abstract][Full Text] [Related]
32. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
Rosner MH; Ronco C
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716
[TBL] [Abstract][Full Text] [Related]
33. Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
Decaux G; Gankam Kengne F
Expert Rev Endocrinol Metab; 2020 May; 15(3):195-214. PubMed ID: 32401559
[No Abstract] [Full Text] [Related]
34. Vasopressin antagonism: potential impact on neurologic disease.
Rabinstein AA
Clin Neuropharmacol; 2006; 29(2):87-93. PubMed ID: 16614541
[TBL] [Abstract][Full Text] [Related]
35. Vaptans: A new option in the management of hyponatremia.
Aditya S; Rattan A
Int J Appl Basic Med Res; 2012 Jul; 2(2):77-83. PubMed ID: 23776817
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Vaptans in the Treatment of Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): A Systematic Review and Meta-Analysis.
Krisanapan P; Tangpanithandee S; Thongprayoon C; Pattharanitima P; Kleindienst A; Miao J; Craici IM; Mao MA; Cheungpasitporn W
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685548
[TBL] [Abstract][Full Text] [Related]
37. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
Gargani L; Schmidt PH; Gheorghiade M
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of hyponatremia in cancer patients.
Castillo JJ; Vincent M; Justice E
Oncologist; 2012; 17(6):756-65. PubMed ID: 22618570
[TBL] [Abstract][Full Text] [Related]
39. Non-peptide arginine-vasopressin antagonists: the vaptans.
Decaux G; Soupart A; Vassart G
Lancet; 2008 May; 371(9624):1624-32. PubMed ID: 18468546
[TBL] [Abstract][Full Text] [Related]
40. [Hyponatremia: from physiopathology to practice].
Passeron A; Dupeux S; Blanchard A
Rev Med Interne; 2010 Apr; 31(4):277-86. PubMed ID: 20153091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
